Immune checkpoint inhibition alters patterns of failure in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy.

J Cancer Res Clin Oncol · 2025 · PMC12579610 · PMID 41175229

Europe PMC DOI

hedged sentence

0.0660

closest p · 1.3× alpha

0.0660

boldest claim

The sentences

showed a trendp = 0.066so close (0.05 < p ≤ 0.1)

Patients with UICC stage IIIA were significantly more likely to die without documented progression ( p = 0.045) and showed a trend toward a lower incidence of BM as the first site of progression ( p = 0.066).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.